End-of-day quote
Other stock markets
|
||
- CHF | - |
Apr. 25 | The specter of stagflation rears its ugly head again | |
Apr. 25 | ROCHE : Barclays lowers target price | CF |
Sales 2024 * | 60B 65.71B | Sales 2025 * | 63.83B 69.91B | Capitalization | 176B 193B |
---|---|---|---|---|---|
Net income 2024 * | 13.31B 14.58B | Net income 2025 * | 14.75B 16.16B | EV / Sales 2024 * | 3.18 x |
Net Debt 2024 * | 14.24B 15.6B | Net Debt 2025 * | 8.17B 8.94B | EV / Sales 2025 * | 2.89 x |
P/E ratio 2024 * |
12.9
x | P/E ratio 2025 * |
11.7
x | Employees | - |
Yield 2024 * |
4.44% | Yield 2025 * |
4.6% | Free-Float | 88.91% |
Latest transcript on Roche Holding Ltd.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 49 | 02-12-31 | |
Severin Schwan
CHM | Chairman | 57 | 07-12-31 |
Alan Hippe
DFI | Director of Finance/CFO | 57 | 11-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Poussot
BRD | Director/Board Member | 72 | 15-03-02 |
Director/Board Member | 59 | - | |
Director/Board Member | 65 | 95-12-31 |
1st Jan change | Capi. | |
---|---|---|
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-12.26% | 149B | |
-6.47% | 146B | |
+2.07% | 117B |